Bausch Health Corp - BHC Net earnings per share (EPS TTM)

Bausch Health Companies (BHC) relies on inelastic demand in gastroenterology and ophthalmology, maintaining moderate pricing power. Production is automated via sterile lines, although formula development requires scientist involvement. Mature assets serve as cash generators despite high debt levels. The current metric level is -2.30, and the GURU.Markets interface illustrates this annual net income per share trend.

BHC (Bausch Health Companies) Net earnings per share for the last four quarters history from 07/04/2022 to 11/15/2026

Analytical breakdowns for Bausch Health Companies

- current quotes and average value forecast:

Price Chart Bausch Health|BHC - Price Target Chart

- issuer market value details:

Market Capitalization Bausch Health|BHC - Business Value

- business book valuation details:

Book Value per Share Bausch Health|BHC - Book Valuation of Business|Market Value to Book Value Ratio bauschhealth.com|BHC - Total Business Assets

- debt burden and liquidity indicators:

- net income and valuation multiples indicators:

BHC - Net Financial Result|Projected Future Earnings Bausch Health Companies|BHC - Price to Earnings Ratio|Forward P/E Multiple Valeant Pharmaceuticals|BHC - Growth-Adjusted Payback Ratio|Enterprise Value to EBITDA Ratio Bausch Health Corp|BHC - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bausch Health|BHC - Earnings per share for the trailing year|Quarterly EPS earnings growth bauschhealth.com|BHC - Earnings per share growth rate in current year|Earnings growth forecast for next year Bausch Health Companies

- total revenue and sales volume data:

BHC - Revenue and Sales Volume|Company Projected Revenue Bausch Health|BHC - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Bausch Health Companies Inc.|BHC - Revenue Change YoY (Last 12 Months)

Fundamental company valuation:bauschhealth.com (BHC)

Manufactured products of Bausch Health Companies Inc.

Trailing twelve-month earnings per share (EPS TTM) measures the portion of profit allocated to each ordinary share, allowing for an assessment of real capital generation efficiency regardless of the total volume of issuance. Analyzing the current rolling annual EPS helps identify margin erosion at Bausch Health Companies (BHC) driven by debt load and the expansion of cheap generics, signaling a loss of the company's competitive advantages.

Competitors of Bausch Health Companies (BHC)